Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
democrats
6
×
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
6
×
texas top stories
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
fda
medicare
clinical study
donald trump
novartis
pricing
republicans
scott gottlieb
senate
approval
bill &
biogen
What
bio
roundup
crispr
house
ipo
moves
plan
price
public
week
airport
allogene
america
anathema
annual
answer
apocalypse
awaited
away
beds
big
biogen
bosley's
bosley’s
bridge
bucks
cancer
cas
celgene
ceo
continues
convoluted
crime
days
democrat
democratic
democrats
dems
departure
details
Language
unset
Current search:
democrats
×
biotech
×
" texas blog main "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More